*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
You are seeing these quotes based on previous browsing related to sectors such as
Vectura Group (VECL)
0.00p
12:50 02/10/24
0.00%0.00p
Today's Low & High
0.00 / 0.00
Open / Previous Close
0.00 / 0.00
52-week range
0.00%0.00p
Volume
0
Market Cap(million)
£0.00m
Advertising
Vectura Group - Overview
Vectura develops inhaled therapies principally for the treatment of respiratory diseases. Inhaled formulation development is increasingly complex with a wide variety of small molecules and biologics, increasing use of combination products and the need for targeted lung delivery or deep lung deposition
for systemic delivery. We offer formulation services for DPI, pMDI and nebuliser development,
including small molecules and biologics, complex combinations and generic products.
Registrars:
Key Personnel
Non-Executive Chairman:
Bruno Angelici
Senior Independent Non-Executive Director:
Jeanne Thoma
Independent Non-Executive Director:
Jeanne Hecht, Kevin Matthews, Per-Olof Andersson , Juliet Thompson
CEO and Executive director:
Will Downie
CFO & Executive Director:
Paul Fry
Contact Details
Address:
One Prospect West, Chippenham, Wiltshire, United Kingdom